These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38918690)

  • 1. Prognostic significance of platelet‑to‑albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases.
    Hua X; Xu F; Shi W; Long ZQ; Huang X; Duan FF; Wang SF; Zhang C; Wang MD; Ni WQ; Xia W; Chen JY; Gao YS
    BMC Cancer; 2024 Jun; 24(1):762. PubMed ID: 38918690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral hemoglobin to albumin ratio predicts prognosis in patients with nasopharyngeal carcinoma underwent concurrent chemoradiotherapy.
    Zhang C; Wang SF; Zhang YL; Teng CX
    BMC Cancer; 2024 Aug; 24(1):1012. PubMed ID: 39148032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram based on circulating CD8
    Yan C; Yang G; Zhang C; Chen K; Sun Y; Liang Z; Lai L; Li L; Qu S; Zhu XD
    Radiat Oncol; 2024 Aug; 19(1):108. PubMed ID: 39138513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
    Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
    Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
    Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
    Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
    Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
    Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
    Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
    Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma.
    Tang W; Long G
    PeerJ; 2024; 12():e17573. PubMed ID: 38915379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
    Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
    Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
    Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
    Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
    Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
    Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up.
    Wang L; Wu Z; Cheng W; Xie D; Lin F; Xia L; Su Y
    Radiat Oncol; 2021 Nov; 16(1):215. PubMed ID: 34742304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma.
    Jiang J; Cai Z; Zheng R; Yuan Y; Lv X; Qiu W
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3707-3715. PubMed ID: 38671169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic modeling for nasopharyngeal carcinoma (NC) undergoing concurrent chemoradiotherapy using clinical and enhanced MRI-Delta radiomics data: A preliminary study.
    Wang Q; An P; Song L; Liu J; Liu J
    Technol Health Care; 2024; 32(4):2381-2394. PubMed ID: 38517817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
    Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
    Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
    Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
    BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.